Christopher David Ozeroff - Net Worth and Insider Trading

Christopher David Ozeroff Net Worth

The estimated net worth of Christopher David Ozeroff is at least $108,299 dollars as of 2024-11-06. Christopher David Ozeroff is the S.V.P., General Counsel of ARCA biopharma Inc and owns about 4,247 shares of ARCA biopharma Inc (ABIO) stock worth over $108,299. Details can be seen in Christopher David Ozeroff's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Christopher David Ozeroff has not made any transactions after 2021-11-22 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Christopher David Ozeroff

To

Christopher David Ozeroff Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Christopher David Ozeroff owns 1 companies in total, including ARCA biopharma Inc (ABIO) .

Click here to see the complete history of Christopher David Ozeroff’s form 4 insider trades.

Insider Ownership Summary of Christopher David Ozeroff

Ticker Comapny Transaction Date Type of Owner
ABIO ARCA biopharma Inc 2021-11-22 S.V.P. & General Counsel

Christopher David Ozeroff Latest Holdings Summary

Christopher David Ozeroff currently owns a total of 1 stock. Christopher David Ozeroff owns 4,247 shares of ARCA biopharma Inc (ABIO) as of November 22, 2021, with a value of $108,299.

Latest Holdings of Christopher David Ozeroff

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ABIO ARCA biopharma Inc 2021-11-22 4,247 25.50 108,299

Holding Weightings of Christopher David Ozeroff


Christopher David Ozeroff Form 4 Trading Tracker

According to the SEC Form 4 filings, Christopher David Ozeroff has made a total of 1 transactions in ARCA biopharma Inc (ABIO) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in ARCA biopharma Inc is the acquisition of 4,167 shares on November 22, 2021, which cost Christopher David Ozeroff around $113,000.

Insider Trading History of Christopher David Ozeroff

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Christopher David Ozeroff Trading Performance

GuruFocus tracks the stock performance after each of Christopher David Ozeroff's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Christopher David Ozeroff is -11.66%. GuruFocus also compares Christopher David Ozeroff's trading performance to market benchmark return within the same time period. The performance of stocks bought by Christopher David Ozeroff within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Christopher David Ozeroff's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Christopher David Ozeroff

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 8.52 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 8.23 LIMIT LIMIT LIMIT LIMIT LIMIT

Christopher David Ozeroff Ownership Network

Ownership Network List of Christopher David Ozeroff

No Data

Ownership Network Relation of Christopher David Ozeroff

Insider Network Chart

Christopher David Ozeroff Owned Company Details

What does ARCA biopharma Inc do?

Who are the key executives at ARCA biopharma Inc?

Christopher David Ozeroff is the S.V.P. & General Counsel of ARCA biopharma Inc. Other key executives at ARCA biopharma Inc include 10 percent owner & other: See Footnote 1 Funicular Funds, Lp , other: See Footnote 1 Funicular Fund, Lp , and other: See Remarks Jacob Ma-weaver .

ARCA biopharma Inc (ABIO) Insider Trades Summary

Over the past 18 months, Christopher David Ozeroff made no insider transaction in ARCA biopharma Inc (ABIO). Other recent insider transactions involving ARCA biopharma Inc (ABIO) include a net purchase of 634,678 shares made by ,

In summary, during the past 3 months, insiders sold 0 shares of ARCA biopharma Inc (ABIO) in total and bought 485 shares, with a net purchase of 485 shares. During the past 18 months, 0 shares of ARCA biopharma Inc (ABIO) were sold and 52,890 shares were bought by its insiders, resulting in a net purchase of 52,890 shares.

ARCA biopharma Inc (ABIO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

ARCA biopharma Inc Insider Transactions

No Available Data

Christopher David Ozeroff Mailing Address

Above is the net worth, insider trading, and ownership report for Christopher David Ozeroff. You might contact Christopher David Ozeroff via mailing address: 8001 Arista Place, Suite 200, Broomfield Co 80021.